We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

146 hedge funds and large institutions have $337M invested in ANI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 28

10% more capital invested

Capital invested by funds: $305M → $337M (+$31.5M)

0.72% less ownership

Funds ownership: 55.82% → 55.1% (-0.72%)

3% less funds holding

Funds holding: 151 → 146 (-5)

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

88% less call options, than puts

Call options by funds: $1.72M | Put options by funds: $14M

Holders
146
Holders Change
-5
Holders Change %
-3.31%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
65
Reduced
28
Closed
23
Calls
$1.72M
Puts
$14M
Net Calls
-$12.3M
Net Calls Change
-$3.52M

Top Buyers

1
BlackRock
BlackRock
New York
+$5.61M
2
WAM
Weiss Asset Management
Massachusetts
+$5.32M
3
MP
Mangrove Partners
Connecticut
+$4.6M
4
JP Morgan Chase
JP Morgan Chase
New York
+$4.48M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.08M

Top Sellers

1
GT
Glenmede Trust
Pennsylvania
-$19.7M
2
PA
Perceptive Advisors
New York
-$5.87M
3
PI
Putnam Investments
Massachusetts
-$3.68M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$3.35M
5
Bank of America
Bank of America
North Carolina
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
VFA
151
Virtus Fund Advisers
Connecticut
– -$295K -6,188 Closed
Squarepoint
152
Squarepoint
New York
– -$285K -6,097 Closed
AQR Capital Management
153
AQR Capital Management
Connecticut
– -$246K -5,264 Closed
DTL
154
Dynamic Technology Lab
Singapore
– -$210K -4,485 Closed
SCM
155
Stevens Capital Management
Pennsylvania
– -$207K -4,417 Closed
Simplex Trading
156
Simplex Trading
Illinois
– -$209K -4,387 Closed
Creative Planning
157
Creative Planning
Kansas
– -$104K -2,218 Closed
Victory Capital Management
158
Victory Capital Management
Texas
– -$89K -1,905 Closed
WAM
159
Wolverine Asset Management
Illinois
– -$53K -1,135 Closed
QT
160
Quantbot Technologies
New York
– -$6K -142 Closed
AIM
161
Acrospire Investment Management
Illinois
– -$2K -48 Closed
FPFS
162
First Personal Financial Services
North Carolina
– -$2K -41 Closed
WEC
163
Winslow Evans & Crocker
Massachusetts
– -$374 -8 Closed
WAM
164
Wealthspire Advisors (Maryland)
Maryland
– +$95 +2 New
PFBT
165
Parkside Financial Bank & Trust
Missouri
– +$286 +6 New
3 4 5 6
7

ANIP Hedge Fund Activity: Q3 2017 in Review

146 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q3 2017, worth a combined $337M — up 10% from $305M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ANIP and 18 opened new positions — a net loss of 5 holders — while 28 trimmed existing stakes and 65 added.

The largest buyer was BlackRock, adding an estimated $5.61M. The largest seller was Glenmede Trust, exiting entirely with an estimated $19.7M sold.

  • 146 institutional investors held ANI Pharmaceuticals (ANIP) as of Q3 2017, down from 151 in Q2 2017.
  • Funds reported $337M of ANI Pharmaceuticals stock for Q3 2017, up 10% quarter-over-quarter.
  • 18 funds opened new ANI Pharmaceuticals positions in Q3 2017 and 23 closed out, a net change of -5 holders.
  • The largest ANI Pharmaceuticals buyer in Q3 2017 was BlackRock, an estimated $5.61M added.
  • The largest ANI Pharmaceuticals seller in Q3 2017 was Glenmede Trust, an estimated $19.7M sold.

Based on aggregated 13F filings for Q3 2017.